Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Projecting future drug expenditures--1992.

P A Ensor1

  • 1Practice Management and Managed Care Department, American Society of Hospital Pharmacists, Bethesda, MD.

American Journal of Hospital Pharmacy
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DEA authority to levy fine for noncompliance with controlled-substance records.

American journal of hospital pharmacy·1992
Same author

How many hospital pharmacists?

American journal of hospital pharmacy·1991
Same journal

National health care reform, Part 2: Response to pharmacists.

American journal of hospital pharmacy·1994
Same journal

Validity of originality assessment.

American journal of hospital pharmacy·1994
Same journal

Unit dose dispensing of chromic phosphate P 32 suspension.

American journal of hospital pharmacy·1994
Same journal

Hydralazine injection still available.

American journal of hospital pharmacy·1994
Same journal

Improved extemporaneous formulation of cyclosporine ophthalmic drops.

American journal of hospital pharmacy·1994
Same journal

Paclitaxel diluent and the case of the slippery spike.

American journal of hospital pharmacy·1994
See all related articles

Future drug spending depends on inflation, generic competition, and new drug approvals. Analyzing historical data and patent expirations helps predict these impacts on pharmaceutical prices.

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Drug Pricing Analysis

Background:

  • Future drug expenditures are influenced by multiple dynamic factors.
  • Understanding these factors is crucial for accurate financial forecasting in healthcare.

Purpose of the Study:

  • To analyze the impact of inflation, generic competition, and new drug entities on future drug expenditures.
  • To provide insights into predicting drug pricing trends.

Main Methods:

  • Utilizing historical data and trend analysis for inflation prediction.
  • Examining patent expiration and market exclusivity for generic competition assessment.
  • Reviewing the new drug application (NDA) to FDA approval timeline for new drug entity forecasting.

Related Experiment Videos

Main Results:

  • Inflation is predicted to increase pharmaceutical prices by 6.4%-10% annually.
  • Generic drug introduction can decrease list prices by 30-70%, stabilizing around 50% of the innovator price.
  • New drug approval processes typically take approximately two years from filing to market.

Conclusions:

  • Accurate assumptions about future drug expenditures require consideration of inflation rates, generic market status, and new drug pipelines.
  • Data sources like the Producer Price Index and HCFA indices are valuable for inflation analysis.
  • Forecasting drug costs necessitates a multi-faceted approach incorporating economic and regulatory factors.